Spruce Biosciences, Inc.
SPRB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16,898 | $110,014 | $50,331 | $203,174 |
| - Cash | $38,753 | $96,339 | $24,487 | $42,748 |
| + Debt | $2,765 | $4,609 | $6,315 | $6,531 |
| Enterprise Value | -$19,090 | $18,284 | $32,159 | $166,957 |
| Revenue | $4,911 | $10,089 | $0 | $0 |
| % Growth | -51.3% | – | – | – |
| Gross Profit | $4,911 | $10,089 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$52,683 | -$47,366 | -$45,686 | -$41,879 |
| % Margin | -1,072.8% | -469.5% | – | – |
| Net Income | -$53,036 | -$47,919 | -$46,180 | -$42,292 |
| % Margin | -1,079.9% | -475% | – | – |
| EPS Diluted | -96.75 | -93 | -72 | -68.25 |
| % Growth | -4% | -29.2% | -5.5% | – |
| Operating Cash Flow | -$55,964 | -$33,275 | -$41,683 | -$35,877 |
| Capital Expenditures | $0 | -$7 | -$8 | -$93 |
| Free Cash Flow | -$55,964 | -$33,282 | -$41,691 | -$35,970 |